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Abstract: Anorganic bovine bone mineral matrix (ABBMM) has been reported to have
osteoconductive properties and no inflammatory or adverse responses when used as grafting
material in sinus augmentation procedures. However, controversy remains in regard to degradation
rate of ABBMM. The aim of this study was to histologically and histomorphometrically evaluate
the degradation of ABBMM in human bone samples obtained in one patient 24 months after
sinus augmentation. Materials and Methods: The histologic and histomorphometric analysis was
performed by means of light microscopy in three specimens harvested from the same patient, Results:
After 24 months the tissue pattern appeared to be composed of residual particles, some in close contact
with the newly formed bone, others separated by translucent areas and osteoid tissues. Newly-formed
bone presented different levels of maturation and numerous osteocytes, with greater numbers in bone
closer to the grafted particles (27.3% vs. 11.2%, p < 0.05). The histomorphometric analysis showed
mean values of 40.84% newly-formed bone, 33.58% residual graft material, 23.84% marrow spaces,
and 1.69% osteoid tissue, Conclusions: Even though ABBMM underwent considerable resorption,
a great amount of residual grafting material was still present after two years of healing following
sinus augmentation. This study confirms that the bovine grafts can be classified as long-term
degradation materials.
Keywords: histology; histomorphometry; anorganic bovine bone mineral matrix; sinus augmentation
1. Introduction
The final goal of any bone grafting procedure should be the achievement of 100% living and
reactive tissue able to undergo a sustained state of remodeling. Autogenous bone has always been
considered the gold standard for grafting procedures because of the reproducible healing mechanism
of osteogenesis, osteoinduction, and osteoconduction [1]. However, autogenous bone also has
disadvantages, including limited amount of available graft material, an additional surgical site,
donor site morbidity, and the requirement of general anesthesia for extraoral bone harvesting [2,3].
Moreover, when used in sinus augmentation, autogenous bone has been reported to be rapidly resorbed
and this might compromise implant placement [4].
In order to overcome these disadvantages, xenogenic bone has been proven as alternative graft
material in bone regeneration [5,6].
Anorganic bovine bone mineral matrix (ABBMM) is by far the most commonly used and
researched xenograft. Most of the available ABBMM consist of deproteinized and sterilized bovine
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bone. Such matrices provide a scaffold for cells migration and are involved in the osseointegration and
remodeling processes [7].
Contrasting data are present in the literature regarding whether ABBMM is completely degradable
and whether the presence of residual graft particles could interfere with the healing process of
regenerated sites [8]. This discrepancy may be attributed to differences in the type of study (animal
vs. human studies), surgical approach, biopsy technique, or histological evaluation method [9].
Non-resorption might result in shielding of the newly-formed bone from physiological stresses
necessary for further remodeling and maturation. Moreover, it could also influence or interfere with
the osseointegration process of dental implants and bone-to-implant contact [1,10]. Residual ABBMM
granules around the dental implant body could represent a locus minoris resistentiae in case of
peri-implant infection [11]. Few human histologic reports on ABBMM resorption rate over time are
available in the literature [12–16]. Histological studies have shown that ABBMM presents a markedly
faster resorption in the initial period (3/6 months) after graft insertion [11,17–19], but it is slowed down
in subsequent time periods [16,20]. Contrasting results are reported in literature also on the biological
interactions occurring at the bone–ABBMM interface [21]. Once the graft particles incorporation in the
bone create a dense and hard tissue network they act similar to the host bone and provide appropriate
biologic support [22–25]. On contrary, the presence of multinucleated cells and osteoclastic activity
surrounding the residual particles suggests that the bone remodeling process may be negatively
influenced [26–29].
It is quite important to understand the effect of residual graft particles at different time periods
and if there is any interference with the natural bone processes that might possibly affect the prognosis
in human.
For that reason, we investigated the biopsies taken from one patient after 24 months of maxillary
sinus augmentation by using ABBMM. The aim of this study was to obtain histomorphometric
measurements of newly-formed bone, marrow spaces, residual biomaterial particles and number of
osteocytes being present.
2. Materials and Methods
A 50-year-old female with a monolateral maxillary edentulism involving the premolar/molar
regions underwent a sinus augmentation procedure in January 2016. The preoperative mean height of
the subantral bone was <4 mm. The patient was a non-smoker and had a non-contributory medical
history. One-hundred percent of ABBMM was used in the surgical procedure. The patient, who
was previously accepted in a study approved by the Ethical Committee of La Sapienza University,
Roma; (reference no. 4597), provided written informed consent for all procedures. The study was
conducted according to the principles embodied in the Helsinki Declaration for biomedical research
involving human.
A thorough preoperative evaluation was performed, including the study of mounted diagnostic
cast and diagnostic wax-up. Radiographic examination included both intraoral and computerized
tomography. Preoperative medications included amoxicillin, and 1 g twice a day of clavulanic acid
(NeoDuplamox, Procter and Gamble), starting one day prior to surgery and continuing until eight
days post-surgery. Patient was asked to rinse with 0.2% chlorhexidine gluconate the day of surgery
and twice a day for 14 days after the procedure.
Under local anesthesia, a crestal incision was made slightly toward the palatal aspect and
throughout the entire length of the edentulous segment, supplemented by buccal releasing incisions
mesially and distally. Full thickness flaps were elevated to expose the alveolar crest and the lateral wall
of the maxillary sinus. A trap door was made in the lateral sinus wall using a round bur under sterile
saline solution irrigation. The door was rotated inward and upward. The sinus membrane was elevated
with curettes of different shapes until it became completely detached from the lateral and inferior wall
of the sinus. The ABBMM (MinerOssX, BioHorizons, Birmingham, AL, USA) was mixed with venous
blood and packed carefully in the sinus cavity. MinerOssX is a natural cancellous (spongiosa) and
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cortical bovine bone matrix with 250–1000 µm particles distribution size. It is produced by a chemical
removal of organic components, has 75–80% porosity and a crystal size of approximately 10 µm [30].
The mucoperiosteal flap was then re-positioned and sutured with multiple horizontal mattress
sutures. Sutures were removed two weeks after surgery. Postsurgical visits were scheduled at monthly
intervals to check the course of healing. The sinus was allowed to heal for 24 months, and then three
implants were placed into the grafted area.
Histologic Analysis
Twenty-four months after maxillary sinus augmentation, three bone cores were harvested, before
implants placement, using a 3.5 mm diameter trephine under cold (4–5 ◦C) sterile saline solution
irrigation. The bone specimens were immediately fixed in 10% buffered formalin and embedded in a
glycolmethacrylate resin. After polymerization, specimens were sectioned along their longitudinal axis
to a thickness of 70 microns (plastic microtome, RM 2265, Leica, Buffalo Grove, IL, USA). Slides were
stained with Trichrome and examined using an Olympus B51 microscope (Olympus America, Lake
Success, NY, USA). The core area of every specimen was chosen for histomorphometric analysis.
Images were captured with a Q-Imaging camera, (Retiga R1™ CCD camera, 32-0013B-157, 12-bit color,
Surrey, BC, Canada) and area fraction percentages of every component in was measured automatically
using Bioquant® image analysis software (R&M Biometrics, Nashville, TN, USA). To evaluate bone
quality, histomorphometric measurements were recorded according to the nomenclature approved by
the American Society of Bone and Mineral Research, and analyzed by a blinded researcher using Ky
Plot 2.0 software (Informer Technologies, Inc., New York, NY, USA).
3. Results
Microscopic examination of processed bone core specimens showed newly-formed bone in close
contact with ABBMM particles (Figure 1).
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Most of the graft particles were surrounded by newly-formed bone. In some areas, the graft
particles were in contact with marrow spaces. The presence of non-mineralized matrix (osteoid seam)
was also observed at the interface with the ABBMM (Figures 2 and 3).
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The newly-formed bone abutting the graft particles showed viable bone and lacunae with
osteocytes. Little granulocytic infiltrate was present in the bone marrow spaces. At higher
magnification, a few multi-nucleated cells at the interface between the biomaterial particles and
new formed bone were detected (Figures 4–6). In addition, many translucent areas at the interface
between the biomaterial particles and newly-formed bone and osteoid tissue were found (Figure 5).
Histomorphometric data are reported in Table 1.
J. Funct. Biomater. 2018, 9, x FOR PEER REVIEW  5 of 10 
 
The newly-formed bone abutting the graft particles showed viable bone and lacunae with 
osteocytes. Little granulocytic infiltrate was present in the bone marrow spaces. At higher 
magnification, a few multi-nucleated cells at the interface between the biomaterial particles and new 
formed bone were detected (Figures 4–6). In addition, many translucent areas at the interface between 
the biomaterial particles and newly-formed bone and osteoid tissue were found (Figure 5). 
Histomorphometric data are reported in Table 1. 
 
Figure 4. Presence of multi-nucleated cells (white arrows) at the interface between the biomaterial 
particles (ABBMM) and newly-formed bone (NB) (trichrome stain ×20). 
 
Figure 5. Presence of translucent areas (white arrows) at the interface between the biomaterial 
particles (ABBMM) and newly-formed bone. Non-mineralized osteoid matrix (*) (trichrome stain 
×40). 
Figure 4. Presence of multi-nucleated cells (white arrows) at the interface between the biomaterial
particles (ABBMM) and newly-formed bone (NB) (trichrome stain ×20).
J. Funct. Biomater. 2018, 9, x FOR PEER REVIEW  5 of 10 
 
The new y-fo med bone abutting the graft particles showed viable bone and lacunae w th 
osteocytes. Littl  granulocytic infiltrate was present in th  bone marrow spaces. At higher 
magnification, a few multi-nucleated cells at the i terface betwee  the biomaterial p rticles and new 
formed bone were detected (Figures 4–6). In addition, many translucent areas at the interface between 
the biomaterial particles and newly-formed bone and osteoid tissue were found (Figure 5). 
Histomorphometric data are reported in Table 1. 
 
Figure 4. Presence of multi-nucleated cells (white arrows) at the interface between the biomaterial 
particles (ABB M) and newly-formed bone (NB) (trichrome stain ×20). 
 
Figure 5. Presence of translucent areas (white arrows) at the interface between the biomaterial 
particles (ABBMM) and newly-formed bone. Non-mineralized osteoid matrix (*) (trichrome stain 
×40). 
Figu e 5. Presence of translucent areas (white arrows) at the interface between the biomaterial particles
(ABBMM) and newly-formed bone. Non-mineralized osteoid matrix (*) (trichrome stain ×40).
J. Funct. Biomater. 2018, 9, 48 6 of 11
J. Funct. Biomater. 2018, 9, x FOR PEER REVIEW  6 of 10 
 
 
Figure 6. Higher magnification of Figure 4 showing multi-nucleated cells in close approximation and 
in contact with ABBMM surface. 
Table 1. Histomorphometric data (mean ± SD). 
Column Mean SD 
Tt. Tissue Area. 7.205 (1.8) 
Tt. Area of Bone 1.952 (0.5) 
Tt. Area of Bone Graft 3.103 (0.9) 
Tt. Osteoid Area 0.095 (0.03) 
Tt. Connective Tissue Area 2.054 (0.8) 
%. Marrow spaces/Tt. Area 23.84 (4.6) 
%. Bone/Tt. Tissue Area 40.84 (3.3) 
%. Graft/Tt. Tissue Area 33.59 (2.8) 
%. Osteoid/Tt. Tissue Area 1.697 (0.4) 
4. Discussion 
It is important to understand the process of new bone formation and remodeling during early 
and late healing phases at sites grafted with ABBMM. The current study presents histomorphometric 
measurements of newly-formed bone, marrow spaces, residual biomaterial particles, and osteocytes 
in biopsies taken from one patient after two years of maxillary sinus augmentation by using ABBMM. 
It was observed that the amount of residual graft material was 33.58%. The results also showed a 
mean value of 40.84% newly-formed bone which is accordance to the previously reported sinuses 
grafted with ABBMM [21]. 
On the other hand, bone sample harvested from one extraction socket regenerated with the same 
ABBMM showed a mean value of 26.85% newly-formed bone after six months [27]. It is difficult to 
make a direct comparison between these two analyzes due to different defect architecture as wells as 
new bone formation, vascularization and graft particles degradation patterns. In addition, other 
study suggests that new bone formation increases over time in sites grafted with ABBMM [29]. More 
specifically, the new bone formation after sinus floor augmentation using ABBMM was about 36% at 
6 months [30], and about 42% at 14 months [31]. Moreover, compared to 12 and 48 months of healing 
histomorphometric data at nine years showed a newly-formed bone increase of 18.45%, and of 8%, 
respectively [16]. 
Figure 6. Higher magnification of Figure 4 showing multi-nucleated cells in close approximation and
in contact with ABBMM surface.
Table 1. Histomorphometric data (mean ± SD).
Column Mean SD
Tt. Tissue Area. 7.205 (1.8)
Tt. Area of Bone 1.952 (0.5)
Tt. Area of Bone Graft 3.103 (0.9)
Tt. Osteoid Area 0.095 (0.03)
Tt. Connective Ti sue 2.054 (0.8)
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4. Discussion
It is important to understand th process of new bone formation and remodeling during early
and late healing phases at sites grafted with ABBMM. The current study presents histomorphometric
measurements of newly-formed bone, marrow spaces, residual biomaterial particles, and osteocytes in
biopsies taken from one patient after two years of maxillary sinus augmentation by using ABBMM.
It was observed that the amount of residual graft material was 33.58%. The results also showed a mean
value of 40.84% newly-formed bone which is accordance to the previously reported sinuses grafted
with ABBMM [21].
On the other hand, bone sample harvested from one extraction socket regenerated with the same
ABBMM showed a mean value of 26.85% newly-formed bone after six months [27]. It is difficult
to make a dir ct compariso between these two analyz s du to different defect architecture as
well as new bon formation, vascularization and graft particles degradation patterns. In addition,
other study suggests that new bone formation increases over time in sites grafted with ABBMM [29].
More specifically, the new bo e formation after sinus floor augmentation using ABBMM was about
36% at 6 months [30], and about 42% at 14 months [31]. Moreover, compared to 12 and 48 months of
healing histomorphometric data at nine years showed a newly-formed bone increase of 18.45%, and of
8%, respectively [16].
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Also the degradation time and ultimate fate of many commercially available bovine grafting
materials at various grafted sites is also not fully understood. There are many variations among
the tested models [13,32–34], cell types [11,34] and the histological preparation methods [9].
While it is generally accepted that graft particles undergo resorption by osteoclasts [15,34–36], it is
documented that multinucleated cells are also present on the surface of the material [7–39]. Its hard to
distinguishing between osteoclasts or macrophage polykaryons and if these cells are active osteoclasts,
nonactive/impaired osteoclasts, giant cells or macrophages/monocytes undergoing fusion [40].
In order to better understand the degradation process, it is important to identify the type of cells
surrounding the ABBMM particles. The histologic sections from the present study demonstrated
multi-nucleated cells in close approximation and in contact with new bone while the osteoblastic
lineage formed new bone onto the ABBMM surface (Figure 6). Such a histologic pattern has been
previously defined as “functional coupling in the bone metabolic unit” [41]. It is suggested that the
multinucleated giant cells observed in the present study could have the function of macrophages
polykaryons. They probably “clean” the graft particles surface from the degradation products and
therefore prepare the conditions for deposition of newly-formed bone [41].
In sites grafted with ABBMM after the first initial healing period (3–6 months), the osteoclastic
activity in the microenvironment around the biomaterial particles could be inhibited by progressive
increase of Ca2+ ions concentration [16]. It has been documented that acid secretion by osteoclasts
causes mineral release from the substratum surface, which leads to an increase in Ca2+ ions in this
compartment [16]. This, in turn, slows down the osteoclastic activity [42]. Ultrastructural analysis
by backscattered electron imaging analysis showed a higher Ca/P ratio in the residual the interface
compared with new bone [43]. This suggests that there may be a gradual diffusion of Ca2+ ions from
the biomaterial into the newly-forming bone at the interface as part of the biomaterial’s resorption
process. The presence of many translucent area at the interface between the biomaterial particles and
newly formed bone and osteoid tissue found in the present study may represent the lytic process of
the graft (Figure 5).
The degradation process of bovine-derived bone depends on the production process that can cause
variations in physicochemical properties, hydrophilicity, and viscoelasticity [44,45]. More specifically,
the high temperature sintering method leads to increased mineral crystalline size, which imparts a
lower degradation rate if compared to the low temperature and chemical treatment methods.
The degradation process is influenced also by pores morphology, degree of porosity, pores’
interconnections, and granule size distribution [46]. A decrease in pore connectivity could influence
the possibility that a greater number of osteoblasts can penetrate the porous structure. In addition,
also the degree of angiogenesis and the resulting flux of nutrient and of oxygen could be lower [47].
Another interesting data documented in the present study is related to the higher mean of
osteocytes/area measured in the bone around the grafted particles compared to those found in
the bone at a distance from the particles. The complex biologic function of osteocytes is still to
be elucidated. It was suggested that osteocyte play a relevant role in the bone homeostasis and
remodeling [48]. Osteocytes may produce signals to control osteoblast and bone lining cell functions,
and thereby regulate bone modeling and help with new bone formation [49,50]. In vitro studies
showed that osteocytes are negative regulator of osteoclast activity and may play a major role in
triggering local bone remodeling [51]. In particular, it has been documented that osteocyte apoptosis
triggers a bone remodeling response, while the neighboring non-apoptotic osteocytes are a major
source of pro-osteoclastogenic signals. Moreover, both the apoptotic and osteoclast signaling osteocyte
populations are localized in a spatially and temporally restricted pattern consistent with the targeted
nature of remodeling response [52]. Lacking sufficient live osteocytes possibly leads to inefficiency
in the remodeling activity. The higher number of osteocytes/area found in the present study in bone
around the grafted particles, compared to bone at a distance from the graft, could be considered a “bone
strategy” to overcome the absence of functional syncytium inside the biomaterial particles [52,53].
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Most of the histological analysis after sinus augmentation report results at implant placement
time during 6 to 9 months post grafting. Even though the present study is limited by the small
sample size of three biopsies taken from one and the same patient, it still gives a general idea
regarding the degradation process of ABBMM following sinus lift procedure after 24 months of
healing. The histologic and histomorphometric analysis showed that a great amount of the residual
grafting material was still present but it was still less than the newly-formed bone. More studies
are required to understand the new bone formation patterns at different time points and in various
grafted defects.
5. Conclusions
The present histologic and histomorphometric analysis was aimed to compare histomorphometric
measures for newly-formed bone, marrow spaces, biomaterial particles remnants, and number of
osteocytes embedded in both trabecular bone and bone tissue near the ABBMM. At two years healing
time following sinus augmentation ABBMM underwent significant degradation. The tissue pattern
appeared composed by residual ABBMM particles in close contact to the newly-formed bone and to
osteoid tissue.
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